title: Therapy of hepatocellular cancer with iodine-131-Lipiodol.
abstract: Most patients with hepatocellular carcinoma are not eligible for surgery at the time of primary diagnosis. Portal vein thrombosis is frequent and represents a contraindication for transarterial chemoembolisation. Transarterial therapy with iodine-131-Lipiodol is superior to systemic therapy in tumours up to diameters of 5 cm and may be performed even in cases with portal vein thrombosis. Compared to other intraarterial therapy procedures, iodine-131-Lipiodol shows the same efficacy but less side effects.
authors.affiliation: Radiology and Nuclear Medicine Institute, von-Stauffenberg-Str. 9, D - 56304 Bad Honnef, Germany. Joern.Risse@freenet.de
authors.forename: Jörn H
authors.initials: JH
authors.lastname: Risse
authors.forename: Christian
authors.initials: C
authors.lastname: Menzel
authors.forename: Frank
authors.initials: F
authors.lastname: Grünwald
authors.forename: Holger
authors.initials: H
authors.lastname: Strunk
authors.forename: Hans-Jürgen
authors.initials: HJ
authors.lastname: Biersack
authors.forename: Holger
authors.initials: H
authors.lastname: Palmedo
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D004338:Drug Combinations; D006801:Humans; D007457:Iodine Radioisotopes / Q000008:administration & dosage / Q000627:therapeutic use*; D007459:Iodized Oil / Q000008:administration & dosage / Q000627:therapeutic use*; D008113:Liver Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D004338:Drug Combinations; D007457:Iodine Radioisotopes; D007459:Iodized Oil